Morbidity and Quality of Life in Bladder Cancer Patients following Cystectomy and Urinary Diversion: A Single-Institution Comparison of Ileal Conduit versus Orthotopic Neobladder

Table 2

Early complications.

Early-onset complications	Ileal conduit; abs. incidence/n; rel. incidence (%)	Ileal neobladder; abs. incidence/n; rel. incidence (%)
Number of patients	146	115
Gastrointestinal	10/145 (6.9%)	19/115 (16.5%)
ileus^a	8/145 (5.5%)	17/115 (14.8%)
rectal injury	2/145 (1.4%)	2/115 (1.7%)
Infectious	19/145 (13.1%)	14/115 (12.2%)
sepsis	13/145 (9.0%)	9/115 (7.8%)
intraabdominal/pelvic abscess	6/145 (4.1%)	5/115 (4.3%)
Wound	30/.146 (20.7%)	18/115 (15.7%)
Infection/dehiscence	30/.146 (20.7%)	18/115 (15.7%)
Urinary tract leakage (urinoma)	3/145 (2.1%)	8/115 (7.0%)
Pulmonary	19/145 (13.1%)	11/115 (9.6%)
pneumonia	19/145 (13.1%)	11/115 (9.6%)
Thromboembolic	10/145 (6.9%)	2/115 (1.7%)
thrombosis	6/145 (4.1%)	1/115 (0.9%)
pulmonary artery embolism	4/145 (2.8%)	1/115 (0.9%)
Lymphocele	10/145 (6.9%)	8/115 (7.0%)
Reoperations	25/146 (17.1%)	12/115 (10.4%)
Overall complication rate^b	69.1%	69.6%

^aFisher’s exact test 𝑃=0.018.
^bPercentage of patients with one or more complications.